The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshoka India Equity Investment Trust Plc Regulatory News (AIE)

Share Price Information for Ashoka India Equity Investment Trust Plc (AIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 264.00
Bid: 262.00
Ask: 264.00
Change: -2.00 (-0.75%)
Spread: 2.00 (0.763%)
Open: 267.00
High: 268.00
Low: 263.00
Prev. Close: 266.00
AIE Live PriceLast checked at -
Ashoka India Equity is an Investment Trust

To achieve long-term capital appreciation, mainly through investment in securities listed in India and listed securities of companies with a significant presence in India.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

7 Mar 2023 10:29

RNS Number : 1613S
Ashoka India Equity Investment Tst
07 March 2023
 

Ashoka India Equity (AIE)

07/03/2023

Results analysis from Kepler Trust Intelligence

Ashoka India Equity (AIE) has released its half-year results for the period ending 31/12/2022. The trust delivered NAV total returns of 10.0% and share price total returns of 9.7%, compared to a 9.9% total return in the MSCI India IMI Index, the trust's benchmark. This was all in GBP terms.

That small level of NAV outperformance builds on the trust's already strong track record. From launch until the end of 2022, the trust delivered NAV total returns of 93.0% in GBP terms. This represented outperformance of 45.8% relative to the benchmark, which produced total returns of 47.2% over the same period, also in GBP terms.

AIE traded at a premium for much of the half-year period, allowing the board to raise a gross amount of £10.4m via the issuance of 5.08m shares. The former figure represented 4.8% of the trust's NAV at period end.

AIE Chairman Andrew Watkins noted that the managers "remain focused on delivering outstanding returns from a diversified portfolio of investments from across the market cap spectrum. The board has great confidence in their abilities to outperform and produce superior returns from one of the world's most dynamic and fastest-growing markets."

Kepler View

Ashoka India Equity (AIE) has built an impressive track record since its launch in 2018. The managers are free to invest across the market cap spectrum and place a heavy emphasis on corporate governance. Along with a proprietary valuation system and a large research team, the managers believe these factors are key to delivering outperformance.

Indian companies escaped much of the volatility that markets experienced in 2022. Inflation has been lower than in most of the developed world and the country was more immune to the fallout from Russia's invasion of Ukraine. However, revelations about alleged fraudulent behaviour from the Adani group of companies in the new year led to a decline in valuations across the board.

We think it's to the managers' credit that they held none of the companies that were discussed in the short seller report which sparked the turmoil around Adani. The managers have always emphasised corporate governance as being one of the cornerstones of their investment process and the events of 2023 have validated their process in that sphere.

It's plausible that the Adani affair will continue to cast a pall over Indian equities in the near term. Beyond the fact that corporate malfeasance can occur anywhere, this should not detract from some of the long-term tailwinds that look to work in India's favour in the future.

Earnings growth for companies in the country remains strong, with investment bank Goldman Sachs estimating that earnings will increase by 17% in 2023 - ahead of China and the wider APAC region. The International Monetary Fund has also estimated that the Indian economy will grow, in real terms, by 6.1% this year, ahead of both the US and China.

We think AIE offers an attractive means by which to access these opportunities. In particular, the managers have argued that the small and mid-size segment of the Indian stock market offers significant opportunities for outperformance, due to its size and the lack of meaningful analyst coverage.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABGGDXRDGDGXR
Date   Source Headline
7th May 20247:00 amRNSBlock Listing Application
3rd May 20241:42 pmRNSNet Asset Value(s)
3rd May 202412:00 pmRNSGeneral Meeting
2nd May 20242:29 pmRNSNet Asset Value(s)
1st May 202412:57 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20245:24 pmRNSIssue of Equity
30th Apr 20241:54 pmRNSNet Asset Value(s)
29th Apr 20245:49 pmRNSIssue of Equity
29th Apr 20242:31 pmRNSNet Asset Value(s)
29th Apr 202412:51 pmRNSHolding(s) in Company
26th Apr 20244:02 pmRNSNet Asset Value(s)
25th Apr 20243:14 pmRNSIssue of Equity
25th Apr 20241:11 pmRNSNet Asset Value(s)
25th Apr 202411:31 amRNSBlock Listing Application
24th Apr 20241:42 pmRNSNet Asset Value(s)
24th Apr 202412:19 pmRNSPublication of a Prospectus
23rd Apr 20241:07 pmRNSNet Asset Value(s)
23rd Apr 20248:49 amRNSHolding(s) in Company
22nd Apr 20242:23 pmRNSNet Asset Value(s)
19th Apr 202412:30 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSBlock listing Interim Review
18th Apr 202412:52 pmRNSNet Asset Value(s)
17th Apr 20242:18 pmRNSNet Asset Value(s)
16th Apr 20242:00 pmRNSNet Asset Value(s)
16th Apr 20247:00 amRNSPublication - Circular & Notice of General Meeting
15th Apr 20242:14 pmRNSNet Asset Value(s)
12th Apr 202412:55 pmRNSNet Asset Value(s)
11th Apr 202412:46 pmRNSNet Asset Value(s)
10th Apr 202412:44 pmRNSNet Asset Value(s)
9th Apr 20245:53 pmRNSIssue of Equity
9th Apr 20241:09 pmRNSNet Asset Value(s)
9th Apr 20247:00 amRNSIssue of Equity
8th Apr 20241:22 pmRNSNet Asset Value(s)
5th Apr 202412:52 pmRNSNet Asset Value(s)
4th Apr 20243:09 pmRNSNet Asset Value(s)
3rd Apr 20241:25 pmRNSNet Asset Value(s)
2nd Apr 20241:24 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20245:41 pmRNSIssue of Equity
28th Mar 20241:09 pmRNSNet Asset Value(s)
27th Mar 20245:27 pmRNSIssue of Equity
27th Mar 202412:54 pmRNSDirector/PDMR Shareholding
27th Mar 202412:41 pmRNSNet Asset Value(s)
26th Mar 20245:40 pmRNSIssue of Equity
26th Mar 20241:05 pmRNSNet Asset Value(s)
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 20244:23 pmRNSIssue of Equity
22nd Mar 20241:47 pmRNSNet Asset Value(s)
21st Mar 20245:21 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.